cilazapril, anhydrous has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Chen, YM; Chiang, WC; Chien, CT; Lin, SL; Tsai, CC; Tsai, TJ | 1 |
| Asai, M; Fukuda, S; Hayashi, M; Kawachi, H; Marumo, T; Monkawa, T; Saruta, T; Shimizu, F; Tsuji, M; Yoshino, J | 1 |
1 trial(s) available for cilazapril, anhydrous and Cirrhosis
| Article | Year |
|---|---|
Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cilazapril; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrosis; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Peptide Fragments; Procollagen; Proteinuria; Renin; Renin-Angiotensin System; Telmisartan; Young Adult | 2008 |
2 other study(ies) available for cilazapril, anhydrous and Cirrhosis
| Article | Year |
|---|---|
Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Division; Cells, Cultured; Chemokine CCL2; Cilazapril; Disease Progression; Down-Regulation; Fibroblasts; Fibrosis; Gene Expression; Glomerular Mesangium; Kidney; Kidney Diseases; Male; Mitosis; Muscle, Smooth; Nephrectomy; Nephritis; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar | 2002 |
Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Blood Pressure; Cilazapril; Drug Therapy, Combination; Fibrosis; Glomerulonephritis, Membranoproliferative; Kidney; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Proteinuria; Rats; Rats, Wistar; Spironolactone; Thy-1 Antigens | 2004 |